Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Skye Bioscience
AddedFeb 15, 2024
UpdatedJul 9, 2026
Skye Bioscience

Skye Bioscience

Public

Nemus Bioscience: Innovating global cannabis-based therapeutics for optimized clinical effects.

HQ
Costa Mesa, CA, US
Founded
2012
Overview
Compare
Fundraising
Employees

Nemus Bioscience is a biopharmaceutical company dedicated to the discovery, development, and commercialization of cannabis-based therapeutics. The company aims to optimize the clinical effects of cannabis-based drugs while minimizing adverse events. Their strategy includes using both natural and synthetic inputs to develop novel drug delivery methods for specific medical indications.

Nemus Bioscience has made significant strides in the biopharmaceutical industry by focusing on innovative cannabis-based treatments. Their work has the potential to impact global healthcare by providing new therapeutic options. The company is recognized for its commitment to advancing medical cannabis research and development.

Skye Bioscience - Similar Companies

Diverse Biotech logo

Diverse Biotech

Biopharmaceutical Research logo

Biopharmaceutical Research

Applied Biosciences logo

Applied Biosciences

Emerald Health Pharmaceuticals logo

Emerald Health Pharmaceuticals

Kadmus Pharmaceuticals logo

Kadmus Pharmaceuticals

Outlier Biopharma logo

Outlier Biopharma

Next Frontier Biosciences logo

Next Frontier Biosciences

Nerx Biosciences logo

Nerx Biosciences

Permeon Biologics logo

Permeon Biologics

permeonbio.com

Franklin Group logo

Franklin Group

Platinum Biosciences logo

Platinum Biosciences

NantBio logo

NantBio

Emerald Health Bioceuticals logo

Emerald Health Bioceuticals

Hemp Synergistics logo

Hemp Synergistics

Symic Biomedical logo

Symic Biomedical

Skye Bioscience - Quick Facts

Who are Skye Bioscience's competitors?

Companies similar to Skye Bioscience include Diverse Biotech, Biopharmaceutical Research, Applied Biosciences and Emerald Health Pharmaceuticals.

When was Skye Bioscience founded?

Skye Bioscience was founded in 2012.

Where is Skye Bioscience's headquarters located?

Skye Bioscience's headquarters is located in Costa Mesa, CA, US.

When was Skye Bioscience's last funding round?

Skye Bioscience's most recent funding round was for $725k (USD) in January 2015.

How much has Skye Bioscience raised to-date?

As of Jan 9, 2015, Skye Bioscience has raised a total of $725k (USD).

How many employees does Skye Bioscience have?

Skye Bioscience has 9 employees as of Feb 4, 2024.

Skye Bioscience - Classification

Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
Customer
  • Enterprise
  • Government
Main Product
  • Drugs
  • Therapeutics
Tags
  • Pharma
Unique IDs
  • secCik: 0001516551
  • ticker: SKYE
NAICS
  • 459900Other Miscellaneous Retailers
  • 459990All Other Miscellaneous Retailers
  • 459991Tobacco, Electronic Cigarette, and Other Smoking Supplies Retailers
  • 450000Retail Trade
  • 459000Sporting Goods, Hobby, Musical Instrument, Book, and Miscellaneous Retailers
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 1 more industry code
NAICS
  • 620000Health Care and Social Assistance